K13V

N/A

Report date: 2025/12/12 15:29:03

NMEFirst In Class

Base Information

Drug NameK13V

Drug Alias NameK13V

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN modulatorsE3 ubiquitin-protein ligase NEDD4 modulators

TargetsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTENE3 ubiquitin-protein ligase NEDD4

Therapy Area/IndicationsDementia, Vascular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPrimary Peptides Inc

China Registration ClassN/A

Develop Information

Active CompaniesPrimary Peptides Inc

Inactive CompaniesN/A

Active IndicationsDementia, Vascular

Inactive IndicationsN/A

Other Information

ATC CodeN/A